These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 29936751

  • 1. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ, Hao HY, Shi XH, Fu ZD, Zhang F, Wang XF, Xu XX, Wang B, Wen HX, Feng SY, Wang B, Wang SP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun 10; 39(6):805-809. PubMed ID: 29936751
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    Yonghao G, Pumei D, Jianhui Y, Jin X, Yanyang Z, Zhe W.
    J Viral Hepat; 2017 Aug 10; 24(8):687-695. PubMed ID: 28199772
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789
    [Abstract] [Full Text] [Related]

  • 6. [Influencing factors for non/low-response to hepatitis-B vaccine in infants of HBsAg positive mothers].
    Wang B, Xu XX, Wen HX, Hao HY, Yang ZQ, Shi XH, Fu ZD, Wang XF, Zhang F, Wang B, Wang SP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul 10; 38(7):911-915. PubMed ID: 28738465
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ, Zhou J, Zhang PZ, Hou HY.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb 10; 21(2):105-10. PubMed ID: 23663881
    [Abstract] [Full Text] [Related]

  • 9. 20 μg hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers.
    Cao M, Wu Y, Wen S, Pan Y, Wang C, Zhang X, Kong F, Lu Y, Wang C, Niu J, Li J, Jiang J.
    Infect Genet Evol; 2018 Sep 10; 63():243-248. PubMed ID: 29883771
    [Abstract] [Full Text] [Related]

  • 10. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F, Zhang G, Zheng H, Miao N, Shen L, Wang F, Dong P, Du F, Chen C, Zhang X, Cui F.
    Vaccine; 2017 Jul 24; 35(33):4229-4235. PubMed ID: 28651839
    [Abstract] [Full Text] [Related]

  • 11. Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers.
    Zhou S, Li T, Allain JP, Zhou B, Zhang Y, Zhong M, Fu Y, Li C.
    J Med Virol; 2017 Dec 24; 89(12):2130-2137. PubMed ID: 28543299
    [Abstract] [Full Text] [Related]

  • 12. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
    Sun KX, Li J, Zhu FC, Liu JX, Li RC, Zhai XJ, Li YP, Chang ZJ, Nie JJ, Zhuang H.
    Vaccine; 2012 Aug 03; 30(36):5335-40. PubMed ID: 22749833
    [Abstract] [Full Text] [Related]

  • 13. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.
    Foaud H, Maklad S, Mahmoud F, El-Karaksy H.
    Infection; 2015 Jun 03; 43(3):307-14. PubMed ID: 25665956
    [Abstract] [Full Text] [Related]

  • 14. [Effect of telbivudine on infants born to HBsAg-positive mothers with non-/hypo-response to hepatitis B vaccine during their second and third trimesters of pregnancy].
    Xu XX, Wang B, Wang XF, Wen HX, Zhang F, Yang ZQ, Hao HY, Wang T, Shi XH, Fu ZD, Wang B, Wang SP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb 10; 38(2):168-172. PubMed ID: 28231660
    [Abstract] [Full Text] [Related]

  • 15. [Relationship between the mode of HBV marker and immune status in neonates and non-/hyporesponse to hepatitis B vaccine].
    Zhang F, Wang SP, Shi XH, Wang XF, Gao Y, Guo J, Zhang LR, Wang T, Wen HX, Xu XX, Yang ZQ, Wang B, Wang B, Feng SY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug 10; 37(8):1074-9. PubMed ID: 27539335
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure.
    Wang C, Wang C, Jia ZF, Wu X, Wen SM, Kong F, Hu KQ, Li J, Jiang J, Niu JQ.
    Medicine (Baltimore); 2016 Aug 10; 95(34):e4390. PubMed ID: 27559947
    [Abstract] [Full Text] [Related]

  • 17. Presence of hepatitis B virus markers in umbilical cord blood: Exposure to or infection with the virus?
    Liu J, Xu B, Chen T, Chen J, Feng J, Xu C, Liu L, Hu Y, Zhou YH.
    Dig Liver Dis; 2019 Jun 10; 51(6):864-869. PubMed ID: 30528568
    [Abstract] [Full Text] [Related]

  • 18. Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
    Chen T, Wang J, Feng Y, Yan Z, Zhang T, Liu M, Bai Y, Song H, Liu H, Yang Y, Liu J, He Y, Chen Y, Zhang S, Zhuang G, Liang X, Liu Z, Xu X, Chen W, Liu Y, Zhao Y.
    BMC Infect Dis; 2013 Nov 06; 13():524. PubMed ID: 24195671
    [Abstract] [Full Text] [Related]

  • 19. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
    Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX.
    J Hepatol; 2011 Dec 06; 55(6):1215-21. PubMed ID: 21703206
    [Abstract] [Full Text] [Related]

  • 20. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ.
    Vaccine; 2001 Jul 16; 19(28-29):3919-26. PubMed ID: 11427266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.